This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 17–19, 2025 | Milan, ItalyMarch 25–26, 2025 | Digital Partnering

William Pay
Venture Partner at Pappas Capital
Speaker

Profile

William joined Pappas Capital in 2023 as a Venture Partner. Prior to this role, he was the Founding Managing Director for Asia at Bryan Garnier & Co. (now part of Stifel), a leading European boutique investment bank headquartered in Paris with over 180 bankers. In this position, he specialized in advising mid-cap, high-growth, and disruptive companies.

William has served as an advisor to EPS Holdings, one of the largest privately held clinical CROs headquartered in Tokyo, Japan, for many years. He also holds an advisory position with the Chairman of Hong Kong WinHealth Pharma Group, a prominent pharmaceutical company with close to 1,000 staff globally and a total enterprise value exceeding 750 million USD. The company focuses on the commercialization of rare diseases and specialty pharmaceuticals in the Greater China region.

Before transitioning to the investment sector, William's last corporate role was with Bayer Healthcare in the Far East as the Chief of Strategic Sourcing. He led a cross-category strategic sourcing and quality compliance team, managing a volatile supply chain with an annual spend of half a billion euros. Prior to joining Bayer in July 2012, William held various globally-based strategic sourcing and business development/sales marketing positions of increasing responsibility at Takeda (Singapore), Johnson & Johnson (California), and Pfizer (NYC and Madrid) on the buy side, as well as for PPD (then part of the Carlyle Group and now part of Thermo Fisher) and Quintiles Transnational (now rebranded as IQVIA) on the supply side. His career has spanned over 25 years across Singapore, the US, Europe, and China.

William is a member of the BayHelix Group, a non-profit professional organization of business leaders from the investment and health-tech communities. The group’s mission is to shape the growth of the life sciences industry, foster business collaborations, and share information and career experiences among its members.

Educated in both China and the US, William is based in Wuxi near Shanghai. He is fluent in English and Mandarin Chinese. In his free time, William enjoys traveling, reading, and indulging in Japanese/Korean style saunas during the winter, which help him stay balanced and inspired.

Agenda Sessions

  • Market spotlight: How is innovation from China and Asia reshaping global biopharma?

    09:30